dr sunil chopade | a randomised phase ii study of osimertinib and bevacizumab versus bevacizumab
Published 1 year ago • 24 plays • Length 7:18Download video MP4
Download video MP3
Similar videos
-
9:12
biweekly vs triweekly cabazitaxel & androgen receptor pathway inhibitors for mcrpc|dr. sunil chopade
-
16:03
nurses workshop dr sunil chopade recent advances in targeted therapy and immunotherapy in lungcancer
-
8:52
dr sunil chopade | systemic therapy in mesothelioma chemotherapy & immunotherapy recent advances
-
20:30
panel discussion: advances in lung cancer treatment | crsf 2023 review
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
1:18
inova schar cancer: palliative care provides physical and emotional care
-
1:24
acquired resistance: facing the challenge of immunotherapy in patients with lung cancer
-
0:53
dr. schwartz on the results of the pacific trial
-
3:13
gynecological cancer treatments: past, present, and future
-
1:26
current standards and future prospects for the treatment of hormone refractory prostate cancer
-
3:13
prostate cancer: treatment sequencing and choice
-
1:59
meet neuro-oncologist shiao-pei weathers, m.d.
-
2:05
dr. christopher barbieri - genetic testing for prostate cancer risk assessment
-
2:12
criteria for treatment selection for patients with crpc
-
1:17
efficacy & safety of standard of care cilta-cel in r/r multiple myeloma
-
2:43
lung cancer - part 14 - prognosis
-
0:59
how to get rid of fatigue being a cancer patient? ft. dr roupen
-
1:07:21
seminar │from cell cycle regulation to anti-cancer treatments │dr adrian saurin
-
10:38
prostate cancer: a less-invasive surgical treatment